Majority of U.S. companies may mandate COVID-19 vaccine in coming months - survey
Reuters
Published Sep 01, 2021 12:51PM ET
(Reuters) - More than half of U.S. companies are planning to impose COVID-19 vaccine mandates in the workplace by year end, with almost a quarter considering vaccination as a condition for employment, according to a national survey of nearly 1,000 employers.
In the face of a resurgence in COVID-19 cases, spurred by the highly contagious Delta coronavirus variant, that has strained the U.S. health care system, many companies have come out with mask mandates and changed their vaccination policies.
Google's parent Alphabet (NASDAQ:GOOGL) Inc, Walmart (NYSE:WMT) Inc, and Goldman Sachs Group Inc (NYSE:GS) are among the growing list of employers requiring some or all staff to get the vaccine.
The survey, which polled 961 U.S. companies that together employ around 9.7 million people, found that by the fourth quarter of 2021, over 52% of employers could have one or more vaccine mandate requirements, an increase from 21% currently.
The mandates could range from requiring vaccination for staff to access common areas such as cafeterias to requiring vaccination for all employees, according to the survey conducted by Willis Towers Watson (NASDAQ:WLTW) between Aug. 18 and 25.
Last week, the U.S. Food and Drug Administration granted full approval to the Pfizer (NYSE:PFE) Inc/BioNTech SE COVID-19 vaccine, an important step that could help accelerate vaccine mandates in the United States.
"We expect even more employers to institute vaccine mandates in the wake of FDA approval of the Pfizer vaccine," Willis Towers Watson's population health leader, Jeff Levin-Scherz, said.
The survey found the number of employers that track whether employees have completed their vaccination was increasing, with more companies considering implementing financial incentives for vaccinations.
About 62% of the U.S. population has received at least one dose, while more than half or roughly 52% are fully vaccinated against COVID-19 as of Tuesday, according to the Center for Disease Control and Prevention.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.